Home > Compound List > Compound details
486-84-0 molecular structure
click picture or here to close

1-methyl-9H-pyrido[3,4-b]indole

ChemBase ID: 37475
Molecular Formular: C12H10N2
Molecular Mass: 182.2212
Monoisotopic Mass: 182.08439833
SMILES and InChIs

SMILES:
c1ccc2c(c1)c1c([nH]2)c(ncc1)C
Canonical SMILES:
Cc1nccc2c1[nH]c1c2cccc1
InChI:
InChI=1S/C12H10N2/c1-8-12-10(6-7-13-8)9-4-2-3-5-11(9)14-12/h2-7,14H,1H3
InChIKey:
PSFDQSOCUJVVGF-UHFFFAOYSA-N

Cite this record

CBID:37475 http://www.chembase.cn/molecule-37475.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
1-methyl-9H-pyrido[3,4-b]indole
IUPAC Traditional name
harmane
1-methyl-9H-pyrido[3,4-b]indole
Synonyms
1-Methyl-9H-beta-carboline
ARIBINE
3-Methyl-4-carboline
Loturine
Passiflorin
Harman
Harman
1-Methyl-9H-pyrido[3,4-b]indole
2-Methyl-β-carboline
Aribine
Harmane
1-甲基-9H-吡啶并[3,4-b]吲哚
2-甲基-β-咔啉
阿锐碱
哈尔满碱
CAS Number
486-84-0
EC Number
207-642-2
MDL Number
MFCD00004957
Beilstein Number
143898
PubChem SID
24873706
24846602
161000782
PubChem CID
5281404

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 13.718027  H Acceptors
H Donor LogD (pH = 5.5) 1.4493957 
LogD (pH = 7.4) 1.9892261  Log P 2.0045834 
Molar Refractivity 55.9068 cm3 Polarizability 24.108831 Å3
Polar Surface Area 28.68 Å2 Rotatable Bonds
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Physical Property Safety Information Pharmacology Properties Product Information Bioassay(PubChem)
Solubility
Dilute Aqueous Acid expand Show data source
Apperance
Off-White to Pale Brown Solid expand Show data source
Powder expand Show data source
Melting Point
229-230°C expand Show data source
235-238 °C(lit.) expand Show data source
236-238 °C expand Show data source
Storage Condition
Refrigerator expand Show data source
Storage Warning
IRRITANT expand Show data source
RTECS
UV0280000 expand Show data source
MSDS Link
Download expand Show data source
Download expand Show data source
Download expand Show data source
Download expand Show data source
Download expand Show data source
German water hazard class
3 expand Show data source
TSCA Listed
false expand Show data source
Personal Protective Equipment
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter expand Show data source
Drug Control
stupéfiant expand Show data source
Gene Information
human ... CYP2D6(1565)rat ... Gabra2(29706) expand Show data source
rat ... Gabra2(29706) expand Show data source
Mechanism of Action
GABA-ergic effects expand Show data source
Inhibitor of serotonergic dorsal raphe neurons expand Show data source
Purity
≥98.0% (NT) expand Show data source
98% expand Show data source
Grade
purum expand Show data source
Certificate of Analysis
Download expand Show data source
Download expand Show data source
Biological Source
Alkaloid from Arariba rubra (Rubiaceae), Passiflora incarnata (Passifloraceae) and many other Passiflora spp., and a wide range of spp. in several families. Also present in tobacco smoke. Prod. by Nocardia sp. and Streptomyces sp. expand Show data source
Application(s)
Cytotoxic intercalating agent expand Show data source
Hallucinogen expand Show data source
Sedative expand Show data source
Empirical Formula (Hill Notation)
C12H10N2 expand Show data source

DETAILS

DETAILS

MP Biomedicals MP Biomedicals Sigma Aldrich Sigma Aldrich TRC TRC
MP Biomedicals - 05201596 external link
MP Biomedicals Rare Chemical collection
Sigma Aldrich - 103276 external link
Application
Used as matrix for analysis of cyclodextrins and for sulfated oligosaccharides in combination with DHB as co-matrix.
Biochem/physiol Actions
I1 imidazoline binding site agonist.
Packaging
1 g in glass bottle
Protocols & Applications
Methods of glycosylated protein analysis by Mass Spectrometry
Sigma Aldrich - 51370 external link
Biochem/physiol Actions
I1 imidazoline binding site agonist.
Toronto Research Chemicals - H105000 external link
Harman alkaloid like harmane, harmine, harmalol, harmaline obtained from Banisteriopsis caapi L. showed cytotoxicity, antimicrobial activity against Staphylococcus aureus, Escherichia coli, Proteus vulgaris and Candida albicans.

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • Sigg, E.B., et al.: Arch. Int. Pharmacodyn., 149, 164 (1964)
  • • Saano, V., et al.: Acta Pharmacol. Toxicol., 51, 300 (1964)
  • • Tse, S., et al.: Biochem. Pharmacol., 42, 459 (1964)
  • • Rommelspacher, H., et al.: Eur. J. Pharmacol., 252, 51 (1964)
  • • Louis, E., et a
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle